APP and early-onset autosomal dominant Alzheimer disease: Administration of OLT1177, an NLRP3 inflammasome inhibitor, rescued cognitive impairment and neuroinflammation in an APP/PS1 mouse model of Alzheimer’s disease (Lonnemann et al. 2020).